The Galleri-Medicare study called REACH (Real-world Evidence to Advance Multi-Cancer Early Detection Health Equity) is a non-randomized, observational study of 50,000 Medicare beneficiaries. The ...
Hosted on MSN
GSK’s new study on belantamab mafodotin: A potential game-changer for multiple myeloma treatment
GlaxoSmithKline (GSK) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) has announced a new clinical study titled ‘A Phase 2, Multicenter, Open Label, Non-randomized Study to ...
Chronic back pain is the most common type of pain, affecting around 16 million American adults — and now a new study has revealed some discouraging findings about potential treatments. Only around one ...
For more than three decades, researchers Christine Stabell Benn and Peter Aaby from the Bandim Health Project have conducted randomized trials involving thousands of children in Guinea-Bissau and ...
Exploring the combination with atezolizumab and radiation therapy Study led by Yale University MADRID, Spain and CAMBRIDGE, Mass., Feb. 09, 2026 ...
Hypofractionated lymph node irradiation failed to reduce the frequency of lymphedema after treatment for invasive breast cancer, a randomized trial showed. A 3-week radiation therapy (RT) protocol led ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results